TITLE

Rofecoxib, 25 mg/d, was more effective than rofecoxib, 12.5 mg/d, celecoxib, or acetaminophen in osteoarthritis of the knee

AUTHOR(S)
Meyerhoff, John
PUB. DATE
July 2002
SOURCE
ACP Journal Club;Jul/Aug2002, Vol. 137 Issue 1, p26
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Provides information on a study that investigated whether rofecoxib, celecoxib and acetaminophen are effective and safe in patients with symptomatic osteoarthritis of the knee. Study design and setting; Main outcome measures; Main results; Conclusion.
ACCESSION #
8835519

 

Related Articles

  • S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]. Najm, Wadie I.; Reinsch, Sibylle; Hoehler, Fred; Tobis, Jerome S.; Harvey, Phillip W. // BMC Musculoskeletal Disorders;2004, Vol. 5, p6 

    Background: S-Adenosylmethionine (SAMe) is a dietary supplement used in the management of osteoarthritis (OA) symptoms. Studies evaluating SAMe in the management of OA have been limited to Non Steroidal Anti-inflammatory Drugs (NSAIDs) for comparison. The present study compares the effectiveness...

  • Diclofenac more effective than acetaminophen in osteoarthritis of the knee. Via, R. Marc // Journal of Family Practice; 

    Diclofenac 150 mg/d is more effective in controlling osteoarthritis symptoms than acetaminophen 4 g/d in patients previously requiring an nonsteroidal anti-inflammatory drug (NSAID). Since acetaminophen is less expensive and better tolerated, it is reasonable to attempt a 2-weak trial in all...

  • EFECTUL COMBINAÅ¡IEI ORALE DE CLORHIDRAT DE GLUCOZAMINÄ‚ ÅžI SULFAT DE CONDROITINÄ‚ ASUPRA SIMPTOMELOR DIN GONARTROZÄ‚: UN STUDIU RANDOMIZAT, DUBLU ORB, CONTROLAT PLACEBO. Biro, Anna I.; Georgescu, Lia; Nedelcuţ, C.; Marinescu, C.; Boloşiu, H.D. // Romanian Journal of Rheumatology;2009, Vol. 18 Issue 2, p103 

    Objectives: To evaluate the efficacy of the oral combination of glucosamine hydrochloride (GC) 1500mg and chondroitin sulphate (CS) 1200mg administered once a day for a 6 months period on the symptoms in patients with knee osteoarthritis. Methods: Fifty nine patients with knee osteoarthritis...

  • Guidelines for the non-surgical treatment of osteoarthritis of the hip and knee.  // Australian Journal of Pharmacy;Apr2011, Vol. 92 Issue 1091, p46 

    The article offers information on non-surgical treatment of osteoarthritis of the hip and knee. It is recommended that healthcare professionals should have proper assessment and management of nutrition and exercise lifestyle behavior change. Further, it discusses the pharmacological...

  • Efficacy of Rofecoxib, Celecoxib, and Acetaminophen in Osteoarthritis of the Knee. Geba, Gregory P.; Weaver, Arthur L.; Polis, Adam B.; Dixon, Mary E.; Schnitzer, Thomas J. // JAMA: Journal of the American Medical Association;1/2/2002, Vol. 287 Issue 1, p64 

    Presents a study to assess the relative therapeutic efficacy of the anti-inflammatory drugs rofecoxib, celecoxib, and acetaminophen in adults with osteoarthritis (OA). Context; Objective; Design and setting; Patients; Interventions; Main outcome measures; Results; Conclusion that rofecoxib...

  • A 64 year old woman with knee pain:case presentation.  // BMJ: British Medical Journal (International Edition);6/5/2004, Vol. 328 Issue 7452, p1362 

    This article discusses a case of a 64 year old woman with knee pain. Details of what osteoarthritis is; Recommended treatment for the disease by her general practitioner; Side effects that can be caused by taking the recommended medicine (acetominophen) and drinking alcohol.

  • Efficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck Disease (KBD) patients. Luo, Rui; Liu, Gang; Liu, Wei; Pei, Fuxing; Zhou, Zongke; Li, Jian; Shen, Bin; Kang, Pengde; Xie, Qibing; Ma, Xin // International Orthopaedics;Sep2011, Vol. 35 Issue 9, p1409 

    The objective of this study was to compare the efficacy and tolerability of celecoxib, meloxicam and paracetamol in late Kashin-Beck disease. Adults ( n = 168) with Kashin-Beck disease were randomised in clusters to receive six week courses of celecoxib 200 mg once daily, meloxicam 7.5 mg once...

  • Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials. M. J. Yelland; C. J. Nikles; N. McNairn; C. B. Del Mar; P. J. Schluter; R. M. Brown // Rheumatology;Jan2007, Vol. 46 Issue 1, p135 

    Objective. To assess the use of n-of-1 trials for short-term choice of drugs for osteoarthritis, with particular reference to comparing the efficacy of sustained-release [SR] paracetamol with celecoxib in individual patients.Methods. Evaluation of community-based patients undergoing n-of-1...

  • N-of-1 trials cost effective in Australian setting.  // PharmacoEconomics & Outcomes News;3/8/2008, Issue 548, p7 

    The article discusses research being done on the effectiveness of N-of-1 trials as option for increasing patients' access to high-cost medications in the Australian setting. It references a study by P. A. Scuffham et al, published in the January-February 2008 issue of "Value in Health." The data...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics